CsPbI

Chengqi Liu, Zahir Abdalla, Xiaoqian Wang, Manrui Liu, Yanhui Jiao, Zisheng Tang, Qi Zhang, Yong Liu

Abstract read

In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chengqi LiuState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering (ISMSE), Wuhan University of Technology, Wuhan 430070, China.

Zahir AbdallaState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering (ISMSE), Wuhan University of Technology, Wuhan 430070, China.

Xiaoqian WangState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering (ISMSE), Wuhan University of Technology, Wuhan 430070, China.

Manrui LiuState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering (ISMSE), Wuhan University of Technology, Wuhan 430070, China.

Yanhui JiaoState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering (ISMSE), Wuhan University of Technology, Wuhan 430070, China.

Zisheng TangState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering (ISMSE), Wuhan University of Technology, Wuhan 430070, China.

Qi ZhangState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering (ISMSE), Wuhan University of Technology, Wuhan 430070, China.

Yong LiuState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering (ISMSE), Wuhan University of Technology, Wuhan 430070, China.

Funding

Major Program of the National Natural Science Foundation of China 22293021National innovation and entrepreneurship training program for college students S202210497011National Natural Science Foundation of China 52072281National Natural Science Foundation of China 52103285

6 · The paper itself

Abstract

Metal halide perovskite nanorods hold great promise for optoelectronic applications. However, they tend to undergo phase transitions due to the instability of the crystal phase under environmental conditions, leading to a rapid decline in the fluorescence efficiency. Here, we report a method in which trioctylphosphine (TOP) directly serves as both the surface ligand and solvent to synthesize highly stable α-CsPbI

Indexed as

1D perovskiteCsPbI3 perovskitenanorodssurface ligandsTOP

Identifiers

PMID40271693

DOI10.3390/ma18071518

PMCPMC11990055

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.